Covered recipient · General Payments record
DONOVAN STEPHEN REED
Allopathic & Osteopathic Physicians Ophthalmology Ophthalmic Plastic and Reconstructive Surgery
General Payments · PY2021–2024
$1,527.58
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $743.99 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BIOTISSUE HOLDINGS INC. | $381.43 | 6 |
| Dompe US, Inc. | $121.85 | 1 |
| Amgen Inc. | $121.63 | 1 |
| Stryker Corporation | $90.51 | 1 |
| Tarsus Pharmaceuticals, Inc. | $28.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $121.63 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111685989 | CMS |
| BIOTISSUE HOLDINGS INC. | $123.90 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148781521 | CMS |
| BIOTISSUE HOLDINGS INC. | $39.83 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148778011 | CMS |
| BIOTISSUE HOLDINGS INC. | $133.25 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148770252 | CMS |
| BIOTISSUE HOLDINGS INC. | $37.45 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148769726 | CMS |
| BIOTISSUE HOLDINGS INC. | $23.50 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148783915 | CMS |
| BIOTISSUE HOLDINGS INC. | $23.50 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148760803 | CMS |
| Dompe US, Inc. | $121.85 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151402009 | CMS |
| Stryker Corporation | $90.51 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119955077 | CMS |
| Tarsus Pharmaceuticals, Inc. | $28.57 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139126940 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.